Prognostic value of Laminin-5 in serous adenocarcinomas of the ovary

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3541-3544

  Kohlberger, Petra ^a   Muller Klingspor, Verena ^a   Heinzl, Harald ^a   Obermair, Andreas ^a   Breitenecker, Gerhard ^a   Leodolter, Sepp ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Immunohistochemistry; Laminin; Ovarian cancer

Indexed keywords

KALININ; LAMININ; LAMININ ALPHA 1; LAMININ BETA 2; LAMININ BETA 3; LAMININ GAMMA 2; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BASEMENT MEMBRANE; CYSTADENOCARCINOMA, SEROUS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; STROMAL CELLS; SURVIVAL RATE;

EID: 0036875137     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Määttä M, Virtanen I, Burgeson R and Autio-Harmainen H: Comparative analysis of the distribution of Laminin chains in the basement membranes in some malignant epithelial tumors: The α1 chain of Laminin shows a selected expression pattern in human carcinomas. J Histochem Cytochem 49: 711-725, 2001.
2. Barsky SH, Siegal GP, Jannotta F and Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140-7, 1983.
3. Mishell DR: Stenchever MA, Droegemueller W and Herbst AL: Neoplastic diseases of the ovary. In: Mishell DR. et al. Comprehensive Gynecology, 3rd ed. St. Louis, Mosby-Year Book 1998, pp 901-13.
4. Kaplan EL and Meier P: Neoparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-81, 1958.
5. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K and Tryggvason K: Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55: 4132-9, 1995.
6. Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K and Auer G: Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 91: 1882-7, 1999.
7. Moriya Y, Niki T, Yamada T, Matsuno Y, Kondo H and Hirohashi S: Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 91: 1129-41, 2001.
8. Nordemar S, Kronenwett U, Auer G, Högmo A, lindholm J, Edström S, Tryggvasson K, Linder S and Munck-Wikland E: Lamininrop-5 as a predictor of invasiveness in cancer in situ lesions of the larynx. Anticancer Res 21: 509-12, 2002.